Cargando…

SUN-042 Low Dose Cyproterone Acetate for the Treatment of Transgender Women - a Retrospective Study

Introduction: Transgender women with intact gonads receive lifelong hormonal treatment in order to suppress physiologic androgen production. Cyproterone acetate (CA) is the most comon antiandrogenic drug prescribed for this indication in Europe, with a dose range between 25-100 mg/day. Aim: To asses...

Descripción completa

Detalles Bibliográficos
Autores principales:	Even-Zohar, Naomi, Sofer, Yael, Yaish, Iris, Serebro, Merav, Tordjman, Karen, Greenman, Yona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Reproductive Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208009/ http://dx.doi.org/10.1210/jendso/bvaa046.1412

Ejemplares similares

A Cross Sectional Analysis of the Prevalence of Co-Morbidities in Older Transgender Individuals Receiving Hormone Affirming Therapy in Comparison With the General Population
por: Breda, Ido, et al.
Publicado: (2021)

OR25-5 High Prevalence of Psychopathologies Among Transgender Subjects Presenting at a Large Tertiary Transgender Health Center: Implication for the Treating Clinicians
por: Kerem, Gil, et al.
Publicado: (2019)

OR11-3 Evidence for Preserved Ovarian Reserve in Transgender Men Receiving Testosterone Therapy: Anti-Mullerian Hormone Serum Levels Decrease Modestly after One Year of Treatment
por: Yaish, Iris, et al.
Publicado: (2019)

SAT409 Sublingual Estradiol Only, Compared To Combined Oral Estradiol And Cyproterone Acetate,Offers No Apparent Advantage For Gender Affirming Hormone Therapy (GHAT), In Treatment Naïve Transwomen: Results Of A Prospective Pilot Study
por: Yaish, Iris, et al.
Publicado: (2023)

Endocrinology specialty service for inpatients: an unmet growing need
por: Osher, Esther, et al.
Publicado: (2023)

SAT406 Evaluation Of The Emotional And Cognitive Effects Of Hormone Therapy In Transgender Men And Women
por: Yaish, Iris, et al.
Publicado: (2023)

SUN-043 Galactorrhea and Hyperprolactinemia in a Transgender Female
por: Unnithan, Rachna, et al.
Publicado: (2020)

SAT-LB042 Effect of Dehydroepiandrosterone on the Perimenopausal Ovary
por: Luna, Selva, et al.
Publicado: (2019)

SUN-040 Hormone Replacement Therapy in Transgender Unmasks Testicular Tumor
por: Tran, Kelvin, et al.
Publicado: (2020)

SUN-LB9 Pharmacokinetics of Sublingual Versus Oral Estradiol in Transgender Women
por: Doll, Elizabeth E, et al.
Publicado: (2020)

SUN-048 Cardiometabolic Effects of Cross-Sex Hormone Therapy in Transgender Patients
por: Trebotic, Lana Kosi, et al.
Publicado: (2020)

SUN-050 Isolated Hyperprolactinemia Caused by Chest Binding in a Transgender Male
por: Cunningham, Hayley E, et al.
Publicado: (2020)

SUN-041 Hispanic Medical Student’s Knowledge and Attitudes Towards Transgender Patient’s Care
por: Muns, Sofía, et al.
Publicado: (2020)

Transgender men's preferences when choosing obstetricians and gynecologists
por: Lifshitz, Dror, et al.
Publicado: (2022)

The Effect of the PCSK9 Inhibitor Evolocumab on Aldosterone Secretion among High Cardiovascular Risk Patients: A Pilot Study
por: Izkhakov, Elena, et al.
Publicado: (2021)

SAT394 Over-representation Of Adoptees Among Transgender Subjects Seeking Gender-Affirming-Hormonal-Therapy (GAHT) In A Large Tertiary Medical Center
por: Yaish, Iris, et al.
Publicado: (2023)

SUN-LB8 Cross Sex Hormone Therapy and Breast Cancer in Transgender Male to Female
por: Eldin, Randa Sharag, et al.
Publicado: (2020)

SUN-052 Effects of Cross-Sex Hormone Therapy on Lipid Metabolism in Transgender Women and Men
por: Kelley, Carly, et al.
Publicado: (2020)

SUN-031 Megestrol Acetate for Bodybuilding Resulting in Abrupt Hypothalamic-Pituitary Dysfunction
por: Lessard, Kimberly Kochersperger, et al.
Publicado: (2020)

SUN-LB042 The Novel Androgen 11β-Methyl-19-Nortestosterone Dodecylcarbonate (11β-MNTDC) Effectively Suppresses Gonadotropins and Testosterone in Healthy Men: A Potential Oral Male Hormonal Contraceptive
por: Yuen, Fiona, et al.
Publicado: (2019)

SUN-047 Cosmetic Injection of Silicone in a Transgender Person Leading to Granulomatous Disease with Hypercalcemia and Terminal Kidney Failure
por: Pereira, Cecilia, et al.
Publicado: (2020)

Cyproterone acetate or spironolactone in lowering testosterone concentrations for transgender individuals receiving oestradiol therapy
por: Angus, Lachlan, et al.
Publicado: (2019)

SUN-049 Male Pattern Baldness and Waist-Hip Ratio as Markers of Arterial Stiffness in Transgender Men Undergoing Long-Term Testosterone Therapy
por: Alvares, Leonardo Azevedo Mobilia, et al.
Publicado: (2020)

FRI404 CNS Manifestations Are Linked With Hot Flashes: Analysis Of Real World Data From A Social Network
por: Shaklai, Sigal, et al.
Publicado: (2023)

MON-042 The Effect of Exercise Training on Reproductive and Cardiometabolic Outcomes in Women with Polycystic Ovary Syndrome: A Pilot Randomized Controlled Trial
por: Benham, Jamie L, et al.
Publicado: (2020)

SUN-039 Estradiol Dose and Concentrations in Transfeminine Individuals
por: Nolan, Brendan J, et al.
Publicado: (2020)

SUN-053 Evaluation of a 52-Year-Old Transgender Man During the First Year of Testosterone Therapy - Biochemical Changes, Body Composition and Cardiovascular Aspects at the Ergometric Test: A Case Report
por: Alvares, Leonardo Azevedo Mobilia, et al.
Publicado: (2020)

Voltammetric Determination of Cyproterone Acetate in Pharmaceutical Preparations
por: El-Enany, Nahed, et al.
Publicado: (2010)

Multicenter Analysis of Cardiometabolic-Related Diagnosesin Transgender Adolescents
por: Valentine, Anna, et al.
Publicado: (2021)

LBSAT133 Dilemmas In The Diagnosis Of Osteoporosis In Transgender Population
por: Vasanthaakumar, Vijaykiran P, et al.
Publicado: (2022)

Achieving Physiologic 17-ẞ-Estradiol Levels in Transgender Females on Estradiol Transdermal Patches and Optimal Dosing
por: Trovato, Alexa, et al.
Publicado: (2021)

Management of Recurrent Deep Vein Thrombosis in a Transgender Woman
por: Oguz, Seda Hanife, et al.
Publicado: (2021)

Stability of Weekly Intramuscular Estradiol Cypionate in a Transgender Woman
por: Calzada, Stephanie, et al.
Publicado: (2021)

SUN-196 Generation of Potent Inhibin Analogues
por: Goney, Monica, et al.
Publicado: (2019)

MON-198 Feminizing Regimen Requirements in Transgender Females Following Orchiectomy
por: Korpaisarn, Sira, et al.
Publicado: (2019)

MON-LB042 Health-Related Quality of Life in Women with Polycystic Ovary Syndrome/Anovulatory Androgen Excess versus Local Population-Based Control Women (from the British Columbia Canadian Multicentre Osteoporosis Study [BC CaMos])
por: Liang, Bernice, et al.
Publicado: (2019)

SUN-237 Higher Doses of Testosterone Gel Required in Hypogonadal Men with Obesity to Achieve Therapeutic Replacement - Advice on Dose Titration
por: Mumdzic, Enis, et al.
Publicado: (2019)

SUN-210 Testosterone Replacement Therapy Implicated in Osteonecrosis
por: Yang, Almira, et al.
Publicado: (2019)

SUN-217 Alternate Pathways of Testosterone Action in Testis
por: Talapatra, Arpita
Publicado: (2019)

SUN-030 Tetraorchidism: A Rare Type of Polyorchidism
por: nagaraja, soumya, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pp20faan3137kr8mqls7k5vg6j